A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Company Overview We are a medical technology company focused on applying innovative AI-based technology to an ECG, also known as an “EKG,” to expand and improve an ECG’s clinical usefulness. Our objective is to make an ECG a far more valuable cardiac screening tool by expanding its clinical capability to detect a broader range of heart disease conditions through the development of AI-based ECG algorithms (“AI-ECG”). We are seeking to provide AI-ECG solutions in any care setting worldwide in a manner that best suits different providers, either via our cloud-based application that can receive an upload from one of the millions of ECG devices currently in clinical use or via our proprietary MyoVista wavECG device. The MyoVista wavECG, is a resting 12-lead ECG that will incorporate HeartSciences’ proprietary AI-ECG algorithm designed to provide diagnostic information related to cardiac dysfunction as well as conventional ECG information in the same test.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 9K | 4K | 19K | 5K | - |
| Net Income | -8.5M | - | - | - | -4.8M |
| EPS | $-4.49 | $-9.34 | $-1,874.00 | $-8,000.00 | $-145.00 |
| Free Cash Flow | -7.3M | -7.4M | -6.1M | -5.8M | -3.6M |
| ROIC | -248.5% | - | - | - | -178.1% |
| Gross Margin | 57.9% | 56.8% | 67.3% | 45.7% | - |
| Debt/Equity | 2.50 | 26.98 | 0.21 | 8.96 | -1.29 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -7.8M | -8.4M | -6.3M | -6.1M | -4.7M |
| Operating Margin | -89939.6% | -192013.1% | -33902.0% | -118698.3% | - |
| ROE | -319.9% | - | - | - | - |
| Shares Outstanding | 3M | 2M | 0M | 0M | 0M |
| Metric | 2022 | 2023 | |||
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | N/A | 5K | 19K | 4K | 9K |
| Gross Margin | N/A | 45.7% | 67.3% | 56.8% | 57.9% |
| R&D | 3.0M | 2.5M | 2.9M | 4.4M | 3.3M |
| SG&A | 1.7M | 3.7M | 3.4M | 4.0M | 4.5M |
| EBIT | -4.7M | -6.1M | -6.3M | -8.4M | -7.8M |
| Op. Margin | N/A | -118698.3% | -33902.0% | -192013.1% | -89939.6% |
| Net Income | -4.8M | N/A | N/A | N/A | -8.5M |
| Net Margin | N/A | N/A | N/A | N/A | -97881.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -178.1% | N/A | N/A | N/A | N/M |
| ROE | N/A | N/A | N/A | N/A | -319.9% |
| ROA | -231.1% | N/A | N/A | N/A | -112.3% |
| Cash Flow | |||||
| Op. Cash Flow | -3.6M | -5.8M | -6.1M | -7.4M | -7.3M |
| Free Cash Flow | -3.6M | -5.8M | -6.1M | -7.4M | -7.3M |
| Owner Earnings | -3.7M | -6.0M | -6.5M | -7.7M | -8.5M |
| CapEx | 2K | 18K | 64K | 3K | 4K |
| Maint. CapEx | 27K | 27K | 28K | 38K | 29K |
| Growth CapEx | 0 | 0 | 37K | 0 | 0 |
| D&A | 27K | 27K | 28K | 38K | 29K |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 68K | 248K | 405K | 250K | 1.1M |
| Debt Repayment | 385K | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | 6.0M | -1.3M | -10M | 3.3M | -173K |
| Cash & Equiv. | 918K | 1.7M | 5.8M | 1.1M | 6.8M |
| Long-Term Debt | 4.4M | 500K | N/A | N/A | 422K |
| Debt/Equity | -1.29 | 8.96 | 0.21 | 26.98 | 2.50 |
| Interest Coverage | -12.7 | -25.1 | -17.8 | -16.7 | -16.7 |
| Equity | -6.1M | 231K | 7.3M | 205K | 2.7M |
| Total Assets | 2.1M | 3.3M | 9.5M | 4.2M | 7.6M |
| Total Liabilities | 8.1M | 3.1M | 2.2M | 4.0M | 4.9M |
| Intangibles | N/A | N/A | 1.6M | 1.6M | 1.7M |
| Retained Earnings | -54M | -61M | -67M | -76M | -83M |
| Working Capital | -1.5M | 864K | 5.6M | -1.5M | 830K |
| Current Assets | 1.9M | 2.7M | 7.4M | 2.2M | 5.1M |
| Current Liabilities | 3.5M | 1.8M | 1.8M | 3.7M | 4.3M |
| Per Share Data | |||||
| EPS | -145.00 | -8,000.00 | -1,874.00 | -9.34 | -4.49 |
| Owner EPS | -36.08 | -706.66 | -336.20 | -3.98 | -2.65 |
| Book Value | -58.44 | 26.94 | 378.30 | 0.11 | 0.83 |
| Cash Flow/Share | -35.17 | -674.51 | -313.82 | -3.83 | -2.66 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 0.1M | 0.0M | 0.0M | 1.9M | 3.2M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | -0.4 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 329.7 | 2.6 | 31.6 | 2.4 |
| Price/Sales | N/A | N/A | N/A | N/A | 723.7 |
| FCF Yield | N/A | -7.6% | -32.7% | -114.4% | -117.1% |
| Market Cap | N/A | 76M | 19M | 6.5M | 6.3M |
| Avg. Price | N/A | 151.58 | 46.37 | 4.01 | 1.97 |
| Year-End Price | N/A | 88.80 | 9.70 | 3.35 | 1.97 |
HeartSciences Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 56.6%.
HeartSciences Inc. (HSCS) has a 5-year average return on invested capital (ROIC) of -178.1%. This is below average and may indicate limited pricing power.
HeartSciences Inc. (HSCS) has a market capitalization of $6M. It is classified as a small-cap stock.
HeartSciences Inc. (HSCS) does not currently pay a regular dividend.
HeartSciences Inc. (HSCS) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
HeartSciences Inc. (HSCS) reported annual revenue of $4 thousand in its most recent fiscal year, based on SEC EDGAR filings.
HeartSciences Inc. (HSCS) generated $-7 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
HeartSciences Inc. (HSCS) has a debt-to-equity ratio of 26.98. This indicates higher leverage, which may increase financial risk.
HeartSciences Inc. (HSCS) reported earnings per share (EPS) of $-9.34 in its most recent fiscal year.
HeartSciences Inc. (HSCS) has a 5-year average gross margin of 56.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 4 years of financial data for HeartSciences Inc. (HSCS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
HeartSciences Inc. (HSCS) has a book value per share of $0.11, based on its most recent annual SEC filing.
No recent press releases.